Alembic Pharma shares today: Analysts at Motilal Oswal Financial Services (MOFSL) have retained their Neutral rating on Alembic Pharma, with a target price of ₹860 per share
At 10:45 AM; the Nifty PSU Bank, Nifty Realty and Nifty Auto index were down in the range of 0.67 per cent and 2 per cent, as compared to 0.60 per cent decline in the benchmark Nifty 50.
The brokerage expects the lender's RoA and return on equity (RoE) to improve to 1.0-1.1 per cent and 14.4-15.8 per cent, respectively, over FY27-FY28E, from 0.9 per cent and 11.4 per cent in FY25
Brokerages, however, agree that Trent continues to grow steadily, expand its store network and improve profitability, broadly in line with expectations
Nomura said Bajaj Finance (BAF) has voluntarily revised loss-given-default (LGD) floors across products, resulting in accelerated provisions of ₹1,400 crore in Q3FY26.
Mankind Pharma recorded profit after tax (PAT) of ₹414 crore, up from ₹378 crore in the same quarter last year. Its revenue from operations also grew 11.5 per cent
Textile stocks in focus: Lower reciprocal tariffs and recent trade deals with UK/EU provide multi-year advantage to boost earnings/cashflows by enhancing export base for the sector, believe analysts.
Share price of Avanti Feeds surged 12 per cent to ₹1,078.75 on the BSE in Wednesday's intra-day trade, and surpassed its previous high of ₹999.99 touched on November 13, 2017.